CERVICAL CANCER: INCIDENCE AND MORTALITY (REVIEW)

1. Ageenko A.I. Novel approaches to cancer diagnosis. Theory. Diagnosis. Treatment. Rehabilitation. Moscow: Meditsina XXI, 2004. – 407 p.
2. Aksel' E.M. Statistics of female genital cancer // Opukholi zhenskoy reproduktivnoy sistemy = Women Reproductive System Tumors. 2009. (1). 76–80.
3. Bakirov A.B., Gimranova G.G., Valeeva E.T. et al. Features of skin cancer development at the enterprises for fiberglass production // Ural'skiy meditsinskiy zhurnal = Ural medical journal. (11). 57–58.
4. Bakhlaev I.E., Kovchur P.I., Mihet'ko A.A. et al. Cervical cancer in Karelia // Vestnik Rossiyskogo onkologicheskogo nauchnogo tsentra imeni Nikolaya Nikolayevicha Blokhina Rossiyskoy akademii meditsinskikh nauk = Bulletin of the russian cancer research center named after Nikolay Nikolaevich Blokhin of the Russian academy of medical sciences. 2011. 22. (1). 22–28.
5. Bozhenko V.K., Ashrafyan L.A., Antonova I.B. i dr. Analysis of gene expression of proliferation and apoptosis in cervical intraepithelial neoplasia and cervical cancer // Opukholi zhenskoy reproduktivnoy sistemy = Women Reproductive System Tumors. 2011. (4). 72–75.
6. Bokhman Ya.V. Guide to oncogynecology. Saint-Petersburg: Foliant, 2002. 195–229.
7. Galitskaya M.G. Gayvoronskaya A.G. Human papillomavirus vaccination as a protection against the whole spectrum of HPV-associated diseases in people of different age and sex // Pediatricheskaya farmakologiya = Pediatric pharmacology. 2013. 10. (1). 13–17.
8. Grigoruk O.G., Cherdantseva T.M., Moskvina T.A. i dr. Assessment of cytological detection of cervical adenocarcinoma // Opukholi zhenskoy reproduktivnoy sistemy = Women Reproductive System Tumors. 2016. 12. (2). 52–59.
9. Davydov, M.I. Aksel' E.M. Cancer statistics in Russia and CIS countries in 2006 // Vestnik Rossiyskogo onkologicheskogo nauchnogo tsentra imeni Nikolaya Nikolayevicha Blokhina Rossiyskoy akademii meditsinskikh nauk = Bulletin of the russian cancer research center named after Nikolay Nikolaevich Blokhin of the Russian academy of medical sciences. 2008. 19. (2, Suppl.). 52–90.
10. Cancer in Russia in 2004 (incidence and mortality) / Eds. V.I. Chissov, V.V. Starinskiy, G.V. Petrova. Moscow, 2006. 248 p.
11. Cancer in Russia in 2014 incidence and mortality) / Eds. A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow, 2016. 250 p.
12. Kiselev V.I., Muyzhnek E.L. Molecular mechanisms of developing cervical dysplasia: new knowledge – new possibilities. Moscow, 2011. 20 p.
13. Klyuchareva S.V., Yadykin A.A. Problems in treating papillomavirus infection and ways of their solution // Klinicheskaya dermatologiya i venerologiya = The Russian Journal of Dermatology and Venereology. 2010. (5). 9–18.
14. Kolomiets L.A., Churuksaeva O.N., Urazova L.N. et al. Vaccination against HPV as a primary prevention of cervical cancer. Tomsk, 2008.79 p.
15. Komarova E.L. Current aspects of cytological screening for cervical cancer: review // Opukholi zhenskoy reproduktivnoy sistemy = Women Reproductive System Tumors. 2009. (3–4) 78–83.
16. Krasnopol'skiy V.I., Logutova L.S., Zarochentseva N.V. et al. Results of vaccination against HPV-associated diseases and cervical cancer in the Moscow region // Rossiyskiy vestnik akushera-ginekologa = Russian Bulletin of Obstetrician-Gynecologist. 2015. (3). 9–14.
17. Meyskens F.M., Patel D. Cervical cancer. Causes and prevention // Opukholi zhenskoy reproduktivnoy sistemy = Women Reproductive System Tumors. 2010. (4). 58–63.
18. Navruzova V.S. Analysis of results of surgical treatment for cervical cancer in reproductive aged women // Opukholi zhenskoy reproduktivnoy sistemy = Women Reproductive System Tumors. 2015. (3). 87–96.
19. Nesterova I.V. Features of functioning of antiviral immunity // Citokiny i vospalenie = Cytokines and Inflammation. 2005. 4. (3). 89–94.
20. Novik V.I. Epidemiology of cervical cancer, risk factors, screening // Prakticheskaya onkologiya = Practical oncology. 2002. 3. (3). 156–165.
21. Pisareva L.F., Odincova I.N., Ananina O.A., Bojarkina A.P. Cancer incidence in Siberia and Russian Far East // Sibirskiy onkologicheskiy zhurnal = Siberian journal of oncology. 2015. (1). 68–75.
22. Pisareva L.F., Odintsova I.N., Ananina O.A. et al. Epidemiological aspects of cervical cancer in Siberia and Russian Far East // Profilakticheskaya meditsina = Preventive Medicine. 2014. (2). 69–72.
23. Tanriverdieva Je.K., Zhordania K.I., Zaharova T.I. i dr. Glandular and squamous cell cervical carcinoma: clinical and prognostic characteristics // Opukholi zhenskoy reproduktivnoy sistemy = Women Reproductive System Tumors. 2012. (1). 97–101.
24. Truhachova N.G., Frolova I.G., Kolomiec L.A. et al. Assessment of the extent of cervical cancer involvement by MRI // Sibirskiy onkologicheskiy zhurnal = Siberian journal of oncology. 2015. (2). 64–70.
25. Trushina O.I. Novikova E.G. Role of photodynamic therapy in secondary prevention of virus-associated precancerous cervical lesions // Sibirskiy onkologicheskiy zhurnal = Siberian journal of oncology. 2011. (3). 16–21.
26. Urazova L.N., Vidjaeva I.G. Cervical cancer and papillomavirus: etiopathogenetic aspects (review) // Sibirskiy onkologicheskiy zhurnal = Siberian journal of oncology. 2009. (1). 64–71.
27. Chimitdorzhieva T.N., Kremeneckij I.G. Ecologic situation and cancer incidence in the Republic of Buryatia // Rossiyskiy onkologicheskiy zhurnal = Russian journal of oncology. 2008. (2). 36–38.
28. Chimitdorzhieva T.N., Perinov A.P., Hojkova O.Ch. Cervical cancer incidence and the first experience in studying HPV infection in the Republic of Buryatia // Byulleten' Vostochno-Sibirskogo nauchnogo tsentra Sibirskogo otdeleniya Rossiyskoy akademii meditsinskikh nauk = Bulletin of East Siberian scientific center of Siberian Branch of Russian Academy of Medical Sciences. 2009. (3). 127–130.
29. Chimitdorzhieva T.N., Zhovtun L.M., Zandanov A.O. et al. Analysis of cervical cancer incidence and HPV infection in the regions of Buryatia // Vestnik Buryatskogo gosudarstvennogo universiteta = The Buryat State University Bulletin. 2011. (12). 69–75.
30. Chimitdorzhieva T.N. Cancer incidence in the Republic of Buryatia // Rossiyskiy onkologicheskiy zhurnal = Russian journal of oncology. 2013. (2). 42–46.
31. Chissov V.I., Dar'yalova S.L. Oncology. Moscow: GEOTAR-Media, 2007. 560 p.
32. Churuksaeva O.N., Asadchikova O.N., Kolomiec L.A. et al. Hormonal factors of HPV-associated cervical cancer // Opukholi zhenskoy reproduktivnoy sistemy = Women Reproductive System Tumors. 2010. (4). 54–57.
33. Bermudez A. Neerja B., Eric L. Cancer of the cervix uteri // Int. J. Gynaecol. Obstet. 2015. 131. (Suppl. 2). S88–S95.
34. Burd E.M. Human papillomavirus and cervical cancer // Clin. Microbiol. Rev. 2009. 16. (1). 1–17.
35. Castle P.E., Fetterman B., Poitras N. et al. Variable risk of cervical precancer and cancer after a human papillomavirus-positive test // Obstet. Gynecol. 2011. 117. (3). 650–656.
36. Castellsagu'e X., Diaz M., De Sanjose S. et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention // J. Natl. Cancer. Inst. 2006. 98. 303–315.
37. Cercato M.C., Mariani L., Vocaturo A. Predictors: of human papilloma virus (HBV) infection in Italian women // J. Med. Virol. 2010. 82. (11). 1921–1927.
38. Dalstein V., Bory J., Graesslin O. et al. Human papillomavirus testing for primary cervical cancer scre ening. Basel: Karger, 2006. 103–119.
39. Ferlay J., Bray F., Pisani Petl. Cancer incidence, mortality and prevalence. Worldwide // Globocan 2002: IARC Cancer Base. (5), Version 2.0. Lyon, France: IARC Press, 2004.
40. Ferlay J., Shin H.R., Bray F. et al. Cancer Incidence and Mortality Worldwide: IARC CancerBase № 10. http://globocan.iarc.fr.
41. Ferlay J., Soerjomataram I., Ervik M. et al. Cancer Incidence and Mortality Worldwide: IARC CancerBase № 11. http://globocan.iarc.fr.
42. Garnett T.O., Duerksen-Hughes P.J. Modulation of apoptosis by human papilloma virus (HPV) oncoproteins // Arch. Virol. 2006. 151. (12). 2321-2335.
43. Hamada K., Shirakawa T., Gotoh A. et al. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer // Gynecol. Oncol. 2006. 103. (3). 820-830.
44. Kesic V. Prevention of cervical cancer in Central and Eastern Europe and Central Asia: A challenge for the future // Vaccine. 2013. 31. (Suppl. 7). vii-ix.
45. Kruse A.J., Skaland I., Janssen E.A. et al. Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability // Int. J. Gynecol. Pathol. 2004. 23. (2). 100–109.
46. Lai C.H., Chang C.J., Huang H.J. et al. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery // J. Clin. Oncol. 2007. 25. 3628–3634.
47. Molijn A., Kleter B., Quint W. et al. Molecular diagnosis of human papillomavirus (HPV) infections // J. Clin. Virol. 2005. 32. (1). 43–51.
48. Mosher W. D. Chandra A., Jones J. Sexual behavior and selected health measures: men and women 15–44 years of age, United States, 2002 // Adv. Data. 2005. 362. 1–55.
49. Realacci M., Perrone G.A., Sale P. et al. Detection of oncogenic HPV and identification of 72Arg polymorphic p53 by in situ PCR for clinical routine purposes // Anticancer Res. 2006. 26. (4B). 3095–3103.
50. Sherman C.A., Harvey S.M., Noell J. “Are they still having sex?” STI’s and unintended pregnancy among mid-life women // J. Women Aging. 2005. 17. (3). 41–55.
51. Waggoner S.E., Darcy K.M., Fuhrman B. et al. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: A Gynecologic Oncology Group study // Gynecol. Oncol. 2006. 103. (3). 853–858.
52. Waxman, A.G. Cervical cancer screening in the early post vaccine era // Obstet. Gynecol. Clin. North Am. 2008. 35. 537–548.
53. Wiebe E., Lynette D., Gillian T. Cancer of the cervix uteri // Int. J. Gynaecol. Obstet. 2012. 119. (2). 100–109.
54. Winer R.L., Kiviat N.B., Hughes J.P. et al. Development and duration of human papillomavirus lesions after initial infection // J. Infect. Dis. 2005. 191. 731–738.
55. World Health Organization (WHO). Comprehensive cervical cancer control. A guide to essential practice. Geneva, 2006. 120 p.
56. Zetola N.M., Bernstein K.T., Wong E. et al. Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs // J. Asquir. Immune Defic. Syndr. 2009. 50. (5). 546–551.
57. Zur Hausen H. Disrupted dichotomous intracellular control of Human papillomavirus infection in cancer of the cervix // Cancer. 1994. 343. 955–957.

Chimitdorzhieva T.N. – candidate of medical sciences, associate professor of department of obstetrics and gynecology, e-mail: chtn2008@mail.ru